$ALOT
AstroNova, Inc. Stock $alot

$alot Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000119312514225197 Filed on June 04, 2014

Income Statement

Concept	2014 Q2	2013 Q2
Revenue	$20.77M	$15.49M
YoY Change	34.16%	7.98%
Cost Of Revenue	$12.14M	$9.708M
YoY Change	25.04%	9.82%
Gross Profit	$8.635M	$5.105M
YoY Change	69.15%	-7.18%
Gross Profit Margin	41.57%	32.97%
Selling, General & Admin	$5.565M	$4.714M
YoY Change	18.05%	15.26%
% of Gross Profit	64.45%	92.34%
Research & Development	$1.371M	$1.113M
YoY Change	23.18%	13.57%
% of Gross Profit	15.88%	21.8%
Depreciation & Amortization	$512.0K	$310.0K
YoY Change	65.16%	-8.82%
% of Gross Profit	5.93%	6.07%
Operating Expenses	$6.936M	$5.827M
YoY Change	19.03%	14.93%
Operating Profit	$1.699M	-$722.0K
YoY Change	-335.32%	-267.91%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$121.0K	-$36.00K
YoY Change	236.11%	260.0%
Pretax Income	$1.578M	-$758.0K
YoY Change	-308.18%	-280.48%
Income Tax	$449.0K	-$319.0K
% Of Pretax Income	28.45%
Net Earnings	$1.129M	-$449.0K
YoY Change	-351.45%	-153.45%
Net Earnings / Revenue	5.43%	-2.9%
Basic Earnings Per Share	$0.15	-$0.06
Diluted Earnings Per Share	$0.14	-$0.06
COMMON SHARES
Basic Shares Outstanding	7.601M shares	7.401M shares
Diluted Shares Outstanding	7.848M shares	7.401M shares

Balance Sheet

Concept	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.60M	$32.30M
YoY Change	-11.46%	39.83%
Cash & Equivalents	$10.14M	$12.19M
Short-Term Investments	$18.50M	$20.10M
Other Short-Term Assets	$7.500M	$12.30M
YoY Change	-39.02%	261.76%
Inventory	$16.18M	$11.80M
Prepaid Expenses
Receivables	$12.84M	$8.400M
Other Receivables	$500.0K	$500.0K
Total Short-Term Assets	$65.60M	$65.30M
YoY Change	0.45%	26.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.563M	$7.600M
YoY Change	-0.49%	-30.91%
Goodwill	$991.0K
YoY Change
Intangibles	$3.224M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$500.0K	$500.0K
YoY Change	0.0%	400.0%
Total Long-Term Assets	$5.120M	$9.500M
YoY Change	-46.11%	-34.03%
TOTAL ASSETS
Total Short-Term Assets	$65.60M	$65.30M
Total Long-Term Assets	$5.120M	$9.500M
Total Assets	$78.28M	$74.80M
YoY Change	4.65%	13.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.480M	$2.200M
YoY Change	12.73%	-8.33%
Accrued Expenses	$6.000M	$5.600M
YoY Change	7.14%	36.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.919M	$9.000M
YoY Change	-0.9%	25.0%
LONG-TERM LIABILITIES
Long-Term Debt	$200.0K	$0.00
YoY Change
Other Long-Term Liabilities	$1.000M	$1.300M
YoY Change	-23.08%	62.5%
Total Long-Term Liabilities	$1.200M	$1.300M
YoY Change	-7.69%	62.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.919M	$9.000M
Total Long-Term Liabilities	$1.200M	$1.300M
Total Liabilities	$10.19M	$11.50M
YoY Change	-11.38%	17.35%
SHAREHOLDERS EQUITY
Retained Earnings	$37.80M
YoY Change
Common Stock	$473.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$13.09M
YoY Change
Treasury Stock Shares	1.776M shares
Shareholders Equity	$68.09M	$63.30M
YoY Change
Total Liabilities & Shareholders Equity	$78.28M	$74.80M
YoY Change	4.65%	13.51%

Cashflow Statement

Concept	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	$1.129M	-$449.0K
YoY Change	-351.45%	-153.45%
Depreciation, Depletion And Amortization	$512.0K	$310.0K
YoY Change	65.16%	-8.82%
Cash From Operating Activities	-$2.495M	-$6.973M
YoY Change	-64.22%	-728.2%
INVESTING ACTIVITIES
Capital Expenditures	$292.0K	$113.0K
YoY Change	158.41%	-159.47%
Acquisitions
YoY Change
Other Investing Activities	$4.460M	-$11.59M
YoY Change	-138.48%	819.84%
Cash From Investing Activities	$4.169M	-$11.71M
YoY Change	-135.62%	707.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	125.0K	-130.0K
YoY Change	-196.15%	-74.0%
NET CHANGE
Cash From Operating Activities	-2.495M	-6.973M
Cash From Investing Activities	4.169M	-11.71M
Cash From Financing Activities	125.0K	-130.0K
Net Change In Cash	1.799M	-18.81M
YoY Change	-109.57%	2139.05%
FREE CASH FLOW
Cash From Operating Activities	-$2.495M	-$6.973M
Capital Expenditures	$292.0K	$113.0K
Free Cash Flow	-$2.787M	-$7.086M
YoY Change	-60.67%	-645.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12191000
CY2012Q1	alot	Debt Received Upon Sale Of Operation DebtReceivedUponSaleOfOperation	1000000
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7679142	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	452599	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9455263	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	85044	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.26
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	650472	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.50
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2014Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1776121	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	9.16
CY2014Q2	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1008000
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27743000
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3791000
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	42644000
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2480000
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8919000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	265000
CY2014Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	651000
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2191000
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	68088000
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	37797000
CY2014Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	445000
CY2014Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	12000
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	473000
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78279000
CY2014Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	97000
CY2014Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3497000
CY2014Q2	us-gaap	Liabilities Liabilities	10191000
CY2014Q2	us-gaap	Assets Current AssetsCurrent	65596000
CY2014Q2	us-gaap	Goodwill Goodwill	991000
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3224000
CY2014Q2	us-gaap	Financial Instruments Owned State And Municipal Government Obligations At Fair Value FinancialInstrumentsOwnedStateAndMunicipalGovernmentObligationsAtFairValue	18455000
CY2014Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	18455000
CY2014Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1657000
CY2014Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	440000
CY2014Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	270000
CY2014Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	5110000
CY2014Q2	us-gaap	Assets Assets	78279000
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10140000
CY2014Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	10257000
CY2014Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12844000
CY2014Q2	us-gaap	Inventory Net InventoryNet	16181000
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77964000
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35306000
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1878835
CY2014Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	5120000
CY2014Q2	us-gaap	Inventory Gross InventoryGross	19678000
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3709000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2324921
CY2014Q2	us-gaap	Other Assets OtherAssets	195000
CY2014Q2	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	2120000
CY2014Q2	us-gaap	Notes Receivable Net NotesReceivableNet	690000
CY2014Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	250000
CY2014Q2	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	23565000
CY2014Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1677000
CY2014Q2	us-gaap	Treasury Stock Value TreasuryStockValue	13091000
CY2014Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7764000
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7563000
CY2014Q2	alot	Line Of Credit Receivable Current LineOfCreditReceivableCurrent	220000
CY2014Q2	alot	Product Replacement Reserve ProductReplacementReserve	451000
CY2014Q2	alot	Contract Related To Noncompete Agreement ContractRelatedToNoncompeteAgreement	167000
CY2014Q2	alot	Product Replacement Cost Charged Against Reserve ProductReplacementCostChargedAgainstReserve	221000
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30999000
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9291225	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	106496	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.63
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	736647	shares
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	13000000	shares
CY2014Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1730042	shares
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	9.12
CY2014Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	1131000
CY2014Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27368000
CY2014Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2310000
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	41235000
CY2014Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2374000
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9892000
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	176000
CY2014Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	715000
CY2014Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3130000
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	66614000
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	37201000
CY2014Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	454000
CY2014Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	788000
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	465000
CY2014Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	77000
CY2014Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3194000
CY2014Q1	us-gaap	Liabilities Liabilities	11350000
CY2014Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	836000
CY2014Q1	us-gaap	Assets Current AssetsCurrent	65034000
CY2014Q1	us-gaap	Goodwill Goodwill	991000
CY2014Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3400000
CY2014Q1	us-gaap	Financial Instruments Owned State And Municipal Government Obligations At Fair Value FinancialInstrumentsOwnedStateAndMunicipalGovernmentObligationsAtFairValue	18766000
CY2014Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	18766000
CY2014Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1800000
CY2014Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	852000
CY2014Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	440000
CY2014Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	313000
CY2014Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	4734000
CY2014Q1	us-gaap	Assets Assets	77964000
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8341000
CY2014Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	10722000
CY2014Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	11366000
CY2014Q1	us-gaap	Inventory Net InventoryNet	15178000
CY2014Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34960000
CY2014Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	3917000
CY2014Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	5338000
CY2014Q1	us-gaap	Inventory Gross InventoryGross	18372000
CY2014Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1383000
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3707000
CY2014Q1	us-gaap	Other Assets OtherAssets	194000
CY2014Q1	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	2120000
CY2014Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	250000
CY2014Q1	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	23500000
CY2014Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1673000
CY2014Q1	us-gaap	Treasury Stock Value TreasuryStockValue	12463000
CY2014Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6798000
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7592000
CY2014Q1	alot	Line Of Credit Receivable Current LineOfCreditReceivableCurrent	240000
CY2014Q1	alot	Contract Related To Noncompete Agreement ContractRelatedToNoncompeteAgreement	250000
CY2012Q1	alot	Loan Receivable Interest Rate Stated Percentage LoanReceivableInterestRateStatedPercentage	0.0375	pure
CY2014Q1	alot	Settlement Amount Received From Supplier For Recovery Of Cost And Expenses SettlementAmountReceivedFromSupplierForRecoveryOfCostAndExpenses	450000
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M12D
CY2014Q2	dei	Trading Symbol TradingSymbol	ALOT
CY2014Q2	dei	Entity Registrant Name EntityRegistrantName	ASTRO MED INC /NEW/
CY2014Q2	dei	Amendment Flag AmendmentFlag	false
CY2014Q2	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2014Q2	dei	Document Type DocumentType	10-Q
CY2014Q2	dei	Document Period End Date DocumentPeriodEndDate	2014-05-03
CY2014Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000008146
CY2014Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	247520	shares
CY2014Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2014Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	5834	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016	pure
CY2014Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.70
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2014Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7848300	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.268	pure
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	10.07
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2014Q2	us-gaap	Nature Of Operations NatureOfOperations	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> <b>(1) Overview</b></p> <!-- xbrl,body --> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Headquartered in West Warwick, Rhode Island, Astro-Med Inc. designs, develops, manufactures and distributes a broad range of specialty printers and data acquisition and analysis systems. Our products are distributed through our own sales force and authorized dealers in the United States. We also sell to customers outside of the United States primarily through our Company offices in Canada and Europe as well as with independent dealers and representatives. Astro-Med, Inc. products are sold under the brand names Astro-Med <sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">®</sup> Test & Measurement and QuickLabel <sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top">®</sup> Systems and are employed around the world in a wide range of aerospace, apparel, automotive, avionics, chemical, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging and transportation.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> Unless otherwise indicated, references to “Astro-Med,” the “Company,” “we,” “our,” and “us” in this Quarterly Report on Form 10-Q refer to Astro-Med, Inc. and its consolidated subsidiaries.</p> </div>
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M18D
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	8.53
CY2014Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.20
CY2014Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2495000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.93
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.020	pure
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.15
CY2014Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.71
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	75600	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7600780	shares
CY2014Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	8986	shares
CY2014Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2014Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M24D
CY2014Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	152789	shares
CY2014Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2014Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.14
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	75600	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	15618	shares
CY2014Q2	us-gaap	Gross Profit GrossProfit	8635000
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1578000
CY2014Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1471000
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1218000
CY2014Q2	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2574000
CY2014Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	533000
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	1699000
CY2014Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1129000
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	92000
CY2014Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	166000
CY2014Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	735000
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-121000
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	1129000
CY2014Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1003000
CY2014Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	89000
CY2014Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	89000
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	20774000
CY2014Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	292000
CY2014Q2	us-gaap	Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax	-2355000
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3000
CY2014Q2	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	658000
CY2014Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1691000
CY2014Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1191000
CY2014Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	125000
CY2014Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12139000
CY2014Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	59000
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	131000
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	131000
CY2014Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1799000
CY2014Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4374000
CY2014Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-731000
CY2014Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4169000
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1371000
CY2014Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	512000
CY2014Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2880000
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	6936000
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	449000
CY2014Q2	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1800000
CY2014Q2	alot	Income Tax Expense IncomeTaxExpense	549000
CY2014Q2	alot	Agreement Expiration Date AgreementExpirationDate	2014-01-31
CY2014Q2	alot	Number Of Equity Incentive Plans NumberOfEquityIncentivePlans	1	Equity_Plan
CY2014Q2	alot	Number Of Installments NumberOfInstallments	16	Installment
CY2014Q2	alot	Fees To Non Employee Director FeesToNonEmployeeDirector	7000
CY2014Q2	alot	Income Tax Benefit Favorable Resolution Of Previously Uncertain Tax Position IncomeTaxBenefitFavorableResolutionOfPreviouslyUncertainTaxPosition	100000
CY2014Q2	alot	Non Employee Director Received Restricted Stock Award Value NonEmployeeDirectorReceivedRestrictedStockAwardValue	20000
CY2014Q2	alot	Reservation Of Shares Under Employee Stock Purchase Plan ReservationOfSharesUnderEmployeeStockPurchasePlan	247500	shares
CY2014Q2	alot	Transition Services Period Maximum TransitionServicesPeriodMaximum	P12M
CY2014Q2	alot	Loan Receivable Date Considered For Interest Payments LoanReceivableDateConsideredForInterestPayments	2013-01-30
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.026	pure
CY2013Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6973000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.06
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7401465	shares
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2013Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7401465	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.385	pure
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.79
CY2014Q2	alot	Effective Tax Rate Current Year EffectiveTaxRateCurrentYear	0.285	pure
CY2014Q2	alot	Effective Tax Rate Prior Year EffectiveTaxRatePriorYear	0.421	pure
CY2014Q2	alot	Maximum Disposal Restriction As Percentage Of Restricted Stock Units MaximumDisposalRestrictionAsPercentageOfRestrictedStockUnits	0.50	pure
CY2014Q2	alot	Period To Receive Lower Product Prices From Supplier PeriodToReceiveLowerProductPricesFromSupplier	P3Y
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008	pure
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.06
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	155900	shares
CY2013Q2	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	1745000
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-604000
CY2013Q2	us-gaap	Gross Profit GrossProfit	5105000
CY2013Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-10000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-758000
CY2013Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4755000
CY2013Q2	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	13527000
CY2013Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	521000
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-722000
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-439000
CY2013Q2	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	48000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-154000
CY2013Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	224000
CY2013Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	235000
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-36000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-449000
CY2013Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1049000
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-155000
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	15485000
CY2013Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	113000
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000
CY2013Q2	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	391000
CY2013Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-431000
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1142000
CY2013Q2	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-7000
CY2013Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11705000
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1113000
CY2013Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	310000
CY2013Q2	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1935000
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	5827000
CY2013Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-130000
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	9708000
CY2013Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	21000
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	161000
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	161000
CY2013Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18808000
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3572000
CY2013Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-5077000
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-319000
CY2013Q2	alot	Product Replacement Related Costs ProductReplacementRelatedCosts	672000
CY2013Q2	alot	Antidilutive In Money Options Excluded From Computation Of Earnings Per Share Amount AntidilutiveInMoneyOptionsExcludedFromComputationOfEarningsPerShareAmount	175951	shares

Files In Submission

Name	View Source	Status
0001193125-14-225197-index-headers.html	Edgar Link	pending
0001193125-14-225197-index.html	Edgar Link	pending
0001193125-14-225197.txt	Edgar Link	pending
0001193125-14-225197-xbrl.zip	Edgar Link	pending
alot-20140503.xml	Edgar Link	completed
alot-20140503.xsd	Edgar Link	pending
alot-20140503_cal.xml	Edgar Link	unprocessable
alot-20140503_def.xml	Edgar Link	unprocessable
alot-20140503_lab.xml	Edgar Link	unprocessable
alot-20140503_pre.xml	Edgar Link	unprocessable
d721210d10q.htm	Edgar Link	pending
d721210dex106.htm	Edgar Link	pending
d721210dex108.htm	Edgar Link	pending
d721210dex311.htm	Edgar Link	pending
d721210dex312.htm	Edgar Link	pending
d721210dex321.htm	Edgar Link	pending
d721210dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALOT
AstroNova, Inc. Stock $alot

2014 Q2 Form 10-Q Financial Statement

#000119312514225197 Filed on June 04, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALOT AstroNova, Inc. Stock $alot

2014 Q2 Form 10-Q Financial Statement

#000119312514225197 Filed on June 04, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALOT
AstroNova, Inc. Stock $alot